Logo image of SLAB

SILICON LABORATORIES INC (SLAB) Stock Fundamental Analysis

NASDAQ:SLAB - Nasdaq - US8269191024 - Common Stock - Currency: USD

133.14  -1.51 (-1.12%)

After market: 133.14 0 (0%)

Fundamental Rating

4

Taking everything into account, SLAB scores 4 out of 10 in our fundamental rating. SLAB was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for SLAB as it has an excellent financial health rating, but there are worries on the profitability. SLAB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SLAB has reported negative net income.
SLAB had a positive operating cash flow in the past year.
In multiple years SLAB reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: SLAB reported negative operating cash flow in multiple years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of -8.57%, SLAB is doing worse than 71.82% of the companies in the same industry.
SLAB has a worse Return On Equity (-9.86%) than 66.36% of its industry peers.
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROIC N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

With a decent Gross Margin value of 54.95%, SLAB is doing good in the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Gross Margin of SLAB has declined.
SLAB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

More info and screens

8

2. Health

2.1 Basic Checks

SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
SLAB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SLAB has been reduced compared to 5 years ago.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 18.29 indicates that SLAB is not in any danger for bankruptcy at the moment.
SLAB has a Altman-Z score of 18.29. This is amongst the best in the industry. SLAB outperforms 87.27% of its industry peers.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 18.29
ROIC/WACCN/A
WACC11.37%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SLAB has a Current Ratio of 5.12. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
SLAB has a Current ratio of 5.12. This is in the better half of the industry: SLAB outperforms 75.45% of its industry peers.
SLAB has a Quick Ratio of 4.45. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
SLAB has a better Quick ratio (4.45) than 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 4.45
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

SLAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.76%, which is quite impressive.
Looking at the last year, SLAB shows a very strong growth in Revenue. The Revenue has grown by 29.65%.
Measured over the past years, SLAB shows a small growth in Revenue. The Revenue has been growing by 4.28% on average per year.
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%

3.2 Future

Based on estimates for the next years, SLAB will show a very strong growth in Earnings Per Share. The EPS will grow by 65.71% on average per year.
Based on estimates for the next years, SLAB will show a very strong growth in Revenue. The Revenue will grow by 22.97% on average per year.
EPS Next Y137.74%
EPS Next 2Y86.49%
EPS Next 3Y65.71%
EPS Next 5YN/A
Revenue Next Year34.55%
Revenue Next 2Y27.01%
Revenue Next 3Y22.97%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLAB. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 52.37 indicates a quite expensive valuation of SLAB.
SLAB's Price/Forward Earnings is on the same level as the industry average.
SLAB is valuated rather expensively when we compare the Price/Forward Earnings ratio to 35.31, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 52.37
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SLAB is valued a bit cheaper than the industry average as 61.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 57.76
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

SLAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SLAB's earnings are expected to grow with 65.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.49%
EPS Next 3Y65.71%

More info and screens

0

5. Dividend

5.1 Amount

SLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILICON LABORATORIES INC

NASDAQ:SLAB (8/14/2025, 8:00:02 PM)

After market: 133.14 0 (0%)

133.14

-1.51 (-1.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners106.6%
Inst Owner Change-0.16%
Ins Owners1.88%
Ins Owner Change2.5%
Market Cap4.34B
Analysts73.33
Price Target152.62 (14.63%)
Short Float %4.7%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.72%
Min EPS beat(2)12.85%
Max EPS beat(2)16.59%
EPS beat(4)3
Avg EPS beat(4)16.76%
Min EPS beat(4)-0.51%
Max EPS beat(4)38.1%
EPS beat(8)6
Avg EPS beat(8)13.41%
EPS beat(12)8
Avg EPS beat(12)11.9%
EPS beat(16)12
Avg EPS beat(16)23.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-1.82%
Revenue beat(4)0
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)-1.26%
Revenue beat(8)1
Avg Revenue beat(8)-0.77%
Revenue beat(12)2
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)8.33%
PT rev (3m)14.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)141.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.4%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.37
P/S 6.17
P/FCF 57.76
P/OCF 45.75
P/B 4.09
P/tB 6.6
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)2.54
Fwd EY1.91%
FCF(TTM)2.3
FCFY1.73%
OCF(TTM)2.91
OCFY2.19%
SpS21.59
BVpS32.58
TBVpS20.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM 10.68%
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 44.06%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.12
Quick Ratio 4.45
Altman-Z 18.29
F-Score6
WACC11.37%
ROIC/WACCN/A
Cap/Depr(3y)38.21%
Cap/Depr(5y)38.21%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
EPS Next Y137.74%
EPS Next 2Y86.49%
EPS Next 3Y65.71%
EPS Next 5YN/A
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%
Revenue Next Year34.55%
Revenue Next 2Y27.01%
Revenue Next 3Y22.97%
Revenue Next 5YN/A
EBIT growth 1Y32.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year163.19%
EBIT Next 3Y64.09%
EBIT Next 5YN/A
FCF growth 1Y563.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y724.28%
OCF growth 3YN/A
OCF growth 5YN/A